{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:28:49Z","timestamp":1793852929892,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04220-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:15:00Z","timestamp":1759151700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between the degree of Helicobacter pylori infection and miR-155 and miR-543 expression levels in gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Ziwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"4220_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"4220_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/cgp.20237","volume":"18","author":"UH Weidle","year":"2021","unstructured":"Weidle UH, Birzele F, Nopora A. Micrornas promoting growth of gastric cancer xenografts and correlation to clinical prognosis. Cancer Genomics Proteomics. 2021;18:1\u201315.","journal-title":"Cancer Genomics Proteomics"},{"key":"4220_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"key":"4220_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107216","volume":"205","author":"H Xu","year":"2024","unstructured":"Xu H, Huang K, Shi M, Gong H, Han M, Tian W, et al. Micrornas in Helicobacter pylori-infected gastric cancer: function and clinical application. Pharmacol Res. 2024;205: 107216.","journal-title":"Pharmacol Res"},{"key":"4220_CR5","doi-asserted-by":"publisher","unstructured":"Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: pathogenetic mechanisms. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032895.","DOI":"10.3390\/ijms24032895"},{"key":"4220_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16:57.","journal-title":"J Hematol Oncol"},{"key":"4220_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/2211536611666220322160242","volume":"11","author":"E Mirzajani","year":"2022","unstructured":"Mirzajani E, Vahidi S, Norollahi SE, Samadani AA. Novel biomarkers of microRNAs in gastric cancer: an overview from diagnosis to treatment. Microrna. 2022;11:12\u201324.","journal-title":"Microrna"},{"key":"4220_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","volume":"149","author":"C Rocken","year":"2023","unstructured":"Rocken C. Predictive biomarkers in gastric cancer. J Cancer Res Clin Oncol. 2023;149:467\u201381.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4220_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138: 111528.","journal-title":"Biomed Pharmacother"},{"key":"4220_CR10","doi-asserted-by":"publisher","first-page":"e0249282","DOI":"10.1371\/journal.pone.0249282","volume":"16","author":"R Vasapolli","year":"2021","unstructured":"Vasapolli R, Venerito M, Schirrmeister W, Thon C, Weigt J, Wex T, et al. Inflammatory MicroRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs. PLoS One. 2021;16:e0249282.","journal-title":"PLoS One"},{"key":"4220_CR11","doi-asserted-by":"publisher","unstructured":"Prinz C, Mese K, Weber D. Microrna changes in gastric carcinogenesis: differential dysregulation during Helicobacter pylori and EBV infection. Genes (Basel). 2021. https:\/\/doi.org\/10.3390\/genes12040597.","DOI":"10.3390\/genes12040597"},{"key":"4220_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4068\/cmj.2023.59.3.167","volume":"59","author":"M Karimi","year":"2023","unstructured":"Karimi M, Mohammadnia A, Amini MA, Shamekh AG, Derakhshanfar E, Hosseini F. Overexpression of miR-146a and miR-155 are potentially biomarkers and predict unfavorable relationship between gastric cancer and Helicobacter pylori infection. Chonnam Med J. 2023;59:167\u201373.","journal-title":"Chonnam Med J"},{"key":"4220_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9340499","volume":"2023","author":"Y Jin","year":"2023","unstructured":"Jin Y, Jiang D. GATA6-AS1 via sponging miR-543 to regulate PTEN\/AKT signaling axis suppresses cell proliferation and migration in gastric cancer. Mediators Inflamm. 2023;2023: 9340499.","journal-title":"Mediators Inflamm"},{"key":"4220_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10528-021-10110-6","volume":"60","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zha W, Qian C, Ding A, Mao Z. Circular RNA circ_0001017 sensitizes Cisplatin-resistant gastric cancer cells to chemotherapy by the miR-543\/PHLPP2 axis. Biochem Genet. 2022;60:558\u201375.","journal-title":"Biochem Genet"},{"key":"4220_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41419-019-1859-8","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi Y, Yang Z, Zhang T, Shen L, Li Y, Ding S. SIRT1-targeted miR-543 autophagy inhibition and epithelial-mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer. Cell Death Dis. 2019;10:625.","journal-title":"Cell Death Dis"},{"key":"4220_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/14728222.2021.1971195","volume":"25","author":"E Abdi","year":"2021","unstructured":"Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets. 2021;25:685\u201399.","journal-title":"Expert Opin Ther Targets"},{"key":"4220_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41:747\u201395.","journal-title":"Cancer Commun"},{"key":"4220_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.gpb.2022.04.006","volume":"20","author":"F Xu","year":"2022","unstructured":"Xu F, Wang Y, Ling Y, Zhou C, Wang H, Teschendorff AE, et al. Dbdemc 3.0: functional exploration of differentially expressed miRNAs in cancers of human and model organisms. Genomics Proteomics Bioinformatics. 2022;20:446\u201354.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"24","key":"4220_CR19","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.1002\/cam4.3559","volume":"9","author":"W Yuan","year":"2020","unstructured":"Yuan W, Gao H, Wang G, Miao Y, Jiang K, Zhang K, et al. Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. Cancer Med. 2020;9(24):9632\u201340.","journal-title":"Cancer Med"},{"key":"4220_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jmoldx.2022.04.007","volume":"24","author":"F Ye","year":"2022","unstructured":"Ye F, Feldman DR, Valentino A, So R, Bromberg M, Khan S, et al. Analytical validation and performance characteristics of molecular serum biomarkers, miR-371a-3p and miR-372-3p, for male germ cell tumors, in a clinical laboratory setting. J Mol Diagn. 2022;24:867\u201377.","journal-title":"J Mol Diagn"},{"key":"4220_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.31557\/APJCP.2023.24.1.121","volume":"24","author":"S Mamdouh","year":"2023","unstructured":"Mamdouh S, Sherif H, Romeih M, Elesaily K. Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer. Asian Pac J Cancer Prev. 2023;24:121\u201331.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4220_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033107","volume":"102","author":"YH Han","year":"2023","unstructured":"Han YH, Zhang W, Wang YT, Xiong ZJ, Du Q, Xie Y, et al. Performance evaluation of a novel 14 C-urea breath test (solid scintillation) for the diagnosis of Helicobacter pylori infection. Medicine (Baltimore). 2023;102: e33107.","journal-title":"Medicine (Baltimore)"},{"key":"4220_CR23","doi-asserted-by":"crossref","unstructured":"Li Z, Yan K, Dai X, Rong W. Study on the clinical efficacy of 14-day vonoprazan-based triple regimen in obese patients with Helicobacter pylori infection. J Chemother 2024:1\u20139.","DOI":"10.1080\/1120009X.2024.2405353"},{"key":"4220_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ Lopez","year":"2023","unstructured":"Lopez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181: 103841.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4220_CR25","doi-asserted-by":"publisher","first-page":"144937","DOI":"10.1016\/j.gene.2020.144937","volume":"757","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Vafaee R, Shoorei H, Taheri M. Micrornas in gastric cancer: biomarkers and therapeutic targets. Gene. 2020;757:144937.","journal-title":"Gene"},{"key":"4220_CR26","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5187","author":"J Ouyang","year":"2021","unstructured":"Ouyang J, Xie Z, Lei X, Tang G, Gan R, Yang X. Clinical crosstalk between microRNAs and gastric cancer (review). Int J Oncol. 2021. https:\/\/doi.org\/10.3892\/ijo.2021.5187.","journal-title":"Int J Oncol"},{"key":"4220_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02084-x","volume":"23","author":"X Yu","year":"2024","unstructured":"Yu X, Zhang Y, Luo F, Zhou Q, Zhu L. The role of MicroRNAs in the gastric cancer tumor microenvironment. Mol Cancer. 2024;23: 170.","journal-title":"Mol Cancer"},{"key":"4220_CR28","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3390\/nu13072245","volume":"13","author":"O Zanoaga","year":"2021","unstructured":"Zanoaga O, Braicu C, Chiroi P, Andreea N, Hajjar NA, Margarit S, et al. The role of miR-155 in nutrition: modulating Cancer-Associated inflammation. Nutrients. 2021;13:2245.","journal-title":"Nutrients"},{"key":"4220_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2217\/bmm-2018-0127","volume":"13","author":"Z Nariman-Saleh-Fam","year":"2019","unstructured":"Nariman-Saleh-Fam Z, Saadatian Z, Daraei A, Mansoori Y, Bastami M, Tavakkoli-Bazzaz J. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research. Biomark Med. 2019;13:147\u201359.","journal-title":"Biomark Med"},{"key":"4220_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cbi.2019.01.036","volume":"302","author":"X Liu","year":"2019","unstructured":"Liu X, Gan L, Zhang J. MiR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7. Chem Biol Interact. 2019;302:83\u201392.","journal-title":"Chem Biol Interact"},{"key":"4220_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-020-01229-y","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Tian Z, Tan Y, Lian G, Chen S, Chen S, et al. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. Mol Cancer. 2020;19:109.","journal-title":"Mol Cancer"},{"key":"4220_CR32","doi-asserted-by":"publisher","first-page":"1134785","DOI":"10.3389\/fimmu.2023.1134785","volume":"14","author":"C Lopes","year":"2023","unstructured":"Lopes C, Almeida TC, Pimentel-Nunes P, Dinis-Ribeiro M, Pereira C. Linking dysbiosis to precancerous stomach through inflammation: deeper than and beyond imaging. Front Immunol. 2023;14:1134785.","journal-title":"Front Immunol"},{"key":"4220_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063381","author":"G Christodoulidis","year":"2024","unstructured":"Christodoulidis G, Koumarelas KE, Kouliou MN, Thodou E, Samara M. Gastric cancer in the era of epigenetics. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063381.","journal-title":"Int J Mol Sci"},{"key":"4220_CR34","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12094-023-03094-9","volume":"25","author":"T Tong","year":"2023","unstructured":"Tong T, Zhou Y, Huang Q, Xiao C, Bai Q, Deng B, et al. The regulation roles of MiRNAs in Helicobacter pylori infection. Clin Transl Oncol. 2023;25:1929\u201339.","journal-title":"Clin Transl Oncol"},{"key":"4220_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12029-019-00319-5","volume":"52","author":"N Khayam","year":"2021","unstructured":"Khayam N, Nejad HR, Ashrafi F, Abolhassani M. Expression profile of miRNA-17-3p and miRNA-17-5p genes in gastric cancer patients with Helicobacter pylori infection. J Gastrointest Cancer. 2021;52:130\u20137.","journal-title":"J Gastrointest Cancer"},{"key":"4220_CR36","doi-asserted-by":"crossref","unstructured":"Mohamed N, Behairy O, El-Defrawy M, Elsayed M, Alhusseini N. Role of miRNA-146a and miRNA-125b in Helicobacter pylori. Clin Exp Pediatr 2025.","DOI":"10.3345\/cep.2025.00192"},{"key":"4220_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jcpt.13175","volume":"45","author":"X Geng","year":"2020","unstructured":"Geng X, Sun YY, Fu JJ, Cao L, Li Y. Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma. J Clin Pharm Ther. 2020;45:660\u20135.","journal-title":"J Clin Pharm Ther"},{"key":"4220_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3892\/etm.2021.9650","volume":"21","author":"X Liu","year":"2021","unstructured":"Liu X, Li Y, Li Z, Hou T. MiR-155 promotes proliferation and epithelial-mesenchymal transition of MCF-7 cells. Exp Ther Med. 2021;21:218.","journal-title":"Exp Ther Med"},{"key":"4220_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.15407\/exp-oncology.2023.02.187","volume":"45","author":"OC Kravets capital","year":"2023","unstructured":"Kravets capital OC, Burtyn O, Borikun T, Rossylna O, THE STUDY OF PROGNOSTIC. VALUE OF MicroRNAs (miR-10b AND \u2013\u2009155) AND CDKN2A\/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA. Exp Oncol. 2023;45:187\u201394.","journal-title":"Exp Oncol"},{"key":"4220_CR40","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/OTT.S283026","volume":"14","author":"Y Gu","year":"2021","unstructured":"Gu Y, Wu F, Wang H, Chang J, Wang Y, Li X. Circular RNA circARPP21 acts as a sponge of miR-543 to suppress hepatocellular carcinoma by regulating LIFR. Onco Targets Ther. 2021;14:879\u201390.","journal-title":"Onco Targets Ther"},{"key":"4220_CR41","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.2147\/IJGM.S422523","volume":"16","author":"Q Guo","year":"2023","unstructured":"Guo Q, Liu XL, Zhai K, Chen C, Ke XX, Zhang J, et al. The emerging roles and mechanisms of PAQR3 in human cancer: pathophysiology and therapeutic implications. Int J Gen Med. 2023;16:4321\u20138.","journal-title":"Int J Gen Med"},{"key":"4220_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12935-020-01395-5","volume":"20","author":"L Yin","year":"2020","unstructured":"Yin L, Liu T, Li C, Yan G, Li C, Zhang J, et al. The MRTF-A\/miR-155\/SOX1 pathway mediates gastric cancer migration and invasion. Cancer Cell Int. 2020;20:303.","journal-title":"Cancer Cell Int"},{"key":"4220_CR43","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/cas.13472","volume":"109","author":"Y Qu","year":"2018","unstructured":"Qu Y, Zhang H, Sun W, Han Y, Li S, Qu Y, et al. MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-beta receptor 2. Cancer Sci. 2018;109:618\u201328.","journal-title":"Cancer Sci"},{"key":"4220_CR44","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.omtn.2020.01.024","volume":"19","author":"T Deng","year":"2020","unstructured":"Deng T, Zhang H, Yang H, Wang H, Bai M, Sun W, et al. Exosome miR-155 derived from gastric carcinoma promotes angiogenesis by targeting the c-MYB\/VEGF axis of endothelial cells. Mol Ther Nucleic Acids. 2020;19:1449\u201359.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4220_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2015.11.062","volume":"469","author":"J Li","year":"2016","unstructured":"Li J, Dong G, Wang B, Gao W, Yang Q. MiR-543 promotes gastric cancer cell proliferation by targeting SIRT1. Biochem Biophys Res Commun. 2016;469:15\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"4220_CR46","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.2147\/OTT.S161316","volume":"11","author":"J Xu","year":"2018","unstructured":"Xu J, Wang F, Wang X, He Z, Zhu X. MiRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer. Onco Targets Ther. 2018;11:5075\u201382.","journal-title":"Onco Targets Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04220-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:15:08Z","timestamp":1759151708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04220-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4220"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04220-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study got approval from the Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine and followed the Declaration of Helsinki. (Approval Number: 2020\u2009\u2212\u2009421). Consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"669"}}